Drug Patent Expirations in July 2009
01. Jul, 2009 
0 Comments
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in July 2009
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
| LEVULAN | Dusa | aminolevulinic acid hydrochloride | 5,422,093 | Jul 28, 2009 |
| LEVULAN | Dusa | aminolevulinic acid hydrochloride | 6,710,066 | Jul 28, 2009 |
| OPTIMARK | Mallinckrodt | gadoversetamide | 5,130,120 | Jul 14, 2009 |
| OPTIMARK | Mallinckrodt | gadoversetamide | 5,137,711 | Jul 14, 2009 |
| OPTIMARK IN PLASTIC CONTAINER | Mallinckrodt | gadoversetamide | 5,130,120 | Jul 14, 2009 |
| OPTIMARK IN PLASTIC CONTAINER | Mallinckrodt | gadoversetamide | 5,137,711 | Jul 14, 2009 |
| PAXIL CR | Glaxosmithkline | paroxetine hydrochloride | 5,789,449 | Jul 6, 2009 |
| TRITEC | Glaxosmithkline | ranitidine bismuth citrate | 5,008,256 | Jul 17, 2009 |
Courtesy of DrugPatentWatch.com
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.
No comments yet... Be the first to leave a reply!